Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

Find Out More
University of Bristol Featured PhD Programmes
University of Portsmouth Featured PhD Programmes
University of Oxford Featured PhD Programmes
Coventry University Featured PhD Programmes
Max Planck Society Featured PhD Programmes
"drugs"×
10 miles
    2. >
    3. >

drugs PhD Projects, Programs & Scholarships

We have 244 drugs PhD Projects, Programs & Scholarships

  • "drugs" ×
  • clear all
Order by 
Showing 1 to 10 of 244
  Design of emulgel drug delivery system of sorbitol derivatives gelators to improve the skin permeability of hydrophilic and hydrophobic drugs.
University of Lincoln School of Pharmacy
  Dr T Chalati
Applications accepted all year round
Fee Waiver Scholarships for MSc by Research. This project aims to develop an innovative emulgel-based delivery system for delivery of key hydrophobic drugs, cosmeceutical agents and herbal ingredients through dermal or topical routes of administration as well as improving the skin permeability to hydrophilic drugs.
Details
Type/Funding
  MRC DiMeN Doctoral Training Partnership: Personalised mitochondrial health: a functional and multi-omic assessment to predict individual susceptibility to hepatotoxicity of antiepileptic drugs
University of Liverpool MRC DiMeN Doctoral Training Partnership
  Dr A Chadwick, Dr A Alfirevic, Dr R Jenkins
Application Deadline: 21 January 2019
Background. The realisation that mitochondrial genetics are an important, and under-researched, factor in personalised medicine is growing.
Details
Type/Funding
  Identifying new drugs to combat the virulence mechanisms underlying multidrug-resistant typhoid.
University of Sheffield Department of Biomedical Science
  Dr D Humphreys
Application Deadline: 23 January 2019
Multidrug-resistant typhoid. --------------------------------------------. The world is facing an epidemic of multidrug-resistant (MDR) typhoid fever.
Details
Type/Funding
  Investigating the mechanism of action of dual antiangiogenic/ antineoplastic drugs using organotypic co-culture of fibroblasts and endothelial cells
University of Bradford Faculty of Life Sciences
  Research Group: Institute of Cancer Therapeutics
  Dr J Elies Gomez, Dr K Pors
Applications accepted all year round
An important feature of many types of cancer is the ability to develop abnormal angiogenesis (blood vessel formation); this allows cancer cells to gain access to nutrients and favours metastasis.
Details
Type/Funding
  New Drugs, New Biology, Tomorrow’s Therapies: Design and Characterisation of Novel Cannabinoid Ligands
University of Auckland Faculty of Medical and Health Sciences
  Dr N Grimsey
Applications accepted all year round
Compounds derived from Cannabis sativa, termed “cannabinoids”, primarily exert their effects via two G protein-coupled receptors (GPCRs), Cannabinoid Receptors 1 and 2 (CB1 and CB2).
Details
Type/Funding
  The drugs don’t work for the primary bone cancer osteosarcoma - finding out why and new ones that do!
University of Sheffield Oncology and Metabolism
  Prof A Gartland, Dr M Lawson
Application Deadline: 23 January 2019
Osteosarcoma is the most frequent of all primary cancers of bone and mainly affects young people with a peak of incidence at 18 years.
Details
Type/Funding
  Chemical modulation of cellular redox balance for cancer treatment
University of Birmingham School of Pharmacy
  Dr I Romero-Canelon
Applications accepted all year round
Platinum complexes, cisplatin, oxaliplatin and carboplatin, are the most widely used anticancer drugs. However, these DNA-targeting treatments are a low selectivity approach with deleterious consequences and a high incidence of resistance.
Details
Type/Funding
  MRC DiMeN Doctoral Training Partnership: Genetic epilepsy: identifying mechanisms and potential drug treatments, from nematodes to humans
University of Liverpool MRC DiMeN Doctoral Training Partnership
  Prof A Morgan, Prof A Trevelyan, Dr A Ilie
Application Deadline: 21 January 2019
Epilepsy is a common neurological disorder that has a major impact on patient mortality, morbidity and quality of life. Clinical management remains extremely problematic, held back both by diagnostic and treatment limitations.
Details
Type/Funding
  In vitro assessment of drug sequestration into lysosomes and in silico prediction of implications for drug disposition and therapeutic efficacy
University of Manchester Faculty of Biology, Medicine and Health
  Dr A Galetin, Dr D Hallifax
Applications accepted all year round
Intracellular concentration of a drug is an important determinant of its efficacy, toxicity, and potential drug-drug interactions [1].
Details
Type/Funding
  Development of a novel 3D gut-microbiota model for the assessment of absorption and metabolism of health supplements and therapeutic drugs
Keele University Institute for Science and Technology in Medicine
  Dr P Ragazzon
Application Deadline: 10 December 2019
The gut epithelium is a complex setting of intestinal cells and epithelial cells filled with transporters, enzymes and channels; these cells are then populated by bacteria (microbiota) that help with the metabolism of nutrients and transport into the blood stream.
Details
Type/Funding
Show 10 15 30 per page
4k+

PhD Project & Programmes
Search for PhDs
PhDs by Subject
PhDs by Institution
PhDs by Country
PhDs by Email
Info for students
Postgraduate Open Days
PhD Study Guides
PhD Study Abroad
Funding Your PhD
Postgraduate Advice Forum
Postgraduate Email Updates
Info for advertisers
Advertise your PhD Project & Programmes
Provider Login
Display Advertising
Targeted Emails

FindAPhD. Copyright 2005-2018
All rights reserved.

Meet with top universities

Get funding advice

Win a £1,000 bursary